Dirk M. Behringer
Impact in
- Gastroenterology top 1%
- Gastrointestinal Tumor Research and Treatment
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
Papers in
- Hematology 28
- Hematopoietic Stem Cell Transplantation 16
- Multiple Myeloma Research and Treatments 6
- Acute Myeloid Leukemia Research 6
- Oncology 36
- Cancer Treatment and Pharmacology 7
- Pancreatic and Hepatic Oncology Research 5
- Co-authors
- Klaus B. Mross (8 shared papers)Jürgen Finke (13 shared papers)Roland H. Mertelsmann (13 shared papers)Stephan Mielke (7 shared papers)Alex Sparreboom (4 shared papers)Seth M. Steinberg (2 shared papers)A. Lindemann (8 shared papers)Hartmut Bertz (9 shared papers)
- Journals
- Blood (11 papers)Annals of Oncology (7 papers)Bone Marrow Transplantation (5 papers)British Journal of Haematology (5 papers)European Journal of Cancer (3 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Dirk M. Behringer
81 papers receiving 5.3k citations
Dirk M. Behringer's Hit Papers
Peers
Comparison fields: 5 of 113
- Gastroenterology 390
- Hematology 714
- Pulmonary and Respiratory Medicine 1.9k
- Oncology 1.5k
- Genetics 387
Countries citing papers authored by Dirk M. Behringer
This map shows the geographic impact of Dirk M. Behringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk M. Behringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk M. Behringer more than expected).
Fields of papers citing papers by Dirk M. Behringer
This network shows the impact of papers produced by Dirk M. Behringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk M. Behringer. The network helps show where Dirk M. Behringer may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk M. Behringer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial Hit paper breakdown → | 2019 | 1869 |
| 2 | Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial Hit paper breakdown → | 2016 | 583 |
| 3 | 2005 | 411 | |
| 4 | 2018 | 179 | |
| 5 | 2006 | 143 | |
| 6 | 2020 | 127 | |
| 7 | 2005 | 122 | |
| 8 | 2017 | 111 | |
| 9 | Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy. | 2000 | 77 |
| 10 | 1996 | 75 | |
| 11 | 2016 | 75 | |
| 12 | 2018 | 72 | |
| 13 | 2003 | 67 | |
| 14 | 2004 | 66 | |
| 15 | 2008 | 66 | |
| 16 | 2020 | 64 | |
| 17 | 2000 | 63 | |
| 18 | 1999 | 62 | |
| 19 | Mobilization of peripheral blood progenitor cells for allogeneic transplantation: efficacy and toxicity of a high-dose rhG-CSF regimen. | 1996 | 53 |
| 20 | 2007 | 53 |
About Dirk M. Behringer
Dirk M. Behringer is a scholar working on Hematology, Oncology, Genetics, Immunology and Pathology and Forensic Medicine, having authored 85 papers that have together received 5.4k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (16 papers), Lymphoma Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (9 papers), Immunotherapy and Immune Responses (8 papers), Cancer Treatment and Pharmacology (7 papers), Multiple Myeloma Research and Treatments (6 papers), Acute Myeloid Leukemia Research (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Gastroenterology (390 citations), Hematology (714 citations), Pulmonary and Respiratory Medicine (1.9k citations), Oncology (1.5k citations) and Genetics (387 citations). Dirk M. Behringer has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Klaus B. Mross, Jürgen Finke, Roland H. Mertelsmann, Stephan Mielke, Alex Sparreboom, Seth M. Steinberg, A. Lindemann, Hartmut Bertz, Regina Kunzmann and Christian Dittrich. Their work appears in journals such as Blood, Annals of Oncology, Bone Marrow Transplantation, British Journal of Haematology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.